Published in FEBS J on January 13, 2010
Current developments in the therapy of protozoan infections. Open Med Chem J (2011) 0.93
High-resolution NMR structure of the antimicrobial peptide protegrin-2 in the presence of DPC micelles. J Biomol NMR (2014) 0.77
Structure-Dependent Immune Modulatory Activity of Protegrin-1 Analogs. Antibiotics (Basel) (2014) 0.75
Activity of antimicrobial peptides, alone or combined with conventional antibiotics, against Staphylococcus aureus isolated from the airways of cystic fibrosis patients. Virulence (2016) 0.75
The major surface-metalloprotease of the parasitic protozoan, Leishmania, protects against antimicrobial peptide-induced apoptotic killing. Mol Microbiol (2006) 1.10
Rapid screening of antibiotic toxicity in an automated microdroplet system. Lab Chip (2012) 1.09
Antimicrobial peptide-induced apoptotic death of leishmania results from calcium-de pend ent, caspase-independent mitochondrial toxicity. J Biol Chem (2009) 1.06
Evidence for potential functionality of nuclearly-encoded humanin isoforms. Genomics (2009) 1.04
Prophylactic efficacy of topical temporin A and RNAIII-inhibiting peptide in a subcutaneous rat Pouch model of graft infection attributable to staphylococci with intermediate resistance to glycopeptides. Circulation (2003) 1.02
In vitro activity of the histatin derivative P-113 against multidrug-resistant pathogens responsible for pneumonia in immunocompromised patients. Antimicrob Agents Chemother (2005) 1.00
Structure activity relationship studies on the antimicrobial activity of novel edeine A and D analogues. J Pept Sci (2006) 0.96
Potential therapeutic role of cationic peptides in three experimental models of septic shock. Antimicrob Agents Chemother (2002) 0.94
Efficacy of tachyplesin III, colistin, and imipenem against a multiresistant Pseudomonas aeruginosa strain. Antimicrob Agents Chemother (2007) 0.94
Temporin A alone and in combination with imipenem reduces lethality in a mouse model of staphylococcal sepsis. J Infect Dis (2005) 0.91
Comparing selection on S. aureus between antimicrobial peptides and common antibiotics. PLoS One (2013) 0.91
Potential therapeutic role of histatin derivative P-113d in experimental rat models of Pseudomonas aeruginosa sepsis. J Infect Dis (2004) 0.90
Temporin A is effective in MRSA-infected wounds through bactericidal activity and acceleration of wound repair in a murine model. Peptides (2008) 0.90
The role of Glycyrrhizin, an inhibitor of HMGB1 protein, in anticancer therapy. Arch Immunol Ther Exp (Warsz) (2012) 0.88
Metabolomics in critical care medicine: a new approach to biomarker discovery. Clin Invest Med (2014) 0.87
Comparative activities of cecropin A, melittin, and cecropin A-melittin peptide CA(1-7)M(2-9)NH2 against multidrug-resistant nosocomial isolates of Acinetobacter baumannii. Peptides (2003) 0.86
In vitro activity and killing effect of the synthetic hybrid cecropin A-melittin peptide CA(1-7)M(2-9)NH(2) on methicillin-resistant nosocomial isolates of Staphylococcus aureus and interactions with clinically used antibiotics. Diagn Microbiol Infect Dis (2004) 0.86
Safety profile of antimicrobial peptides: camel, citropin, protegrin, temporin a and lipopeptide on HaCaT keratinocytes. Acta Pol Pharm (2013) 0.85
Therapeutic efficacy of the magainin analogue MSI-78 in different intra-abdominal sepsis rat models. J Antimicrob Chemother (2004) 0.85
Temporin A as a prophylactic agent against methicillin sodium-susceptible and methicillin sodium-resistant Staphylococcus epidermidis vascular graft infection. J Vasc Surg (2002) 0.83
Antimicrobial peptides as potential tool to fight bacterial biofilm. Acta Pol Pharm (2014) 0.82
Activity of short lipopeptides and conventional antimicrobials against planktonic cells and biofilms formed by clinical strains of Staphylococcus aureus. Future Med Chem (2012) 0.82
In vitro activity of aurein 1.2 alone and in combination with antibiotics against gram-positive nosocomial cocci. Antimicrob Agents Chemother (2007) 0.82
In vitro susceptibility of dermatophytes to conventional and alternative antifungal agents. Med Mycol (2008) 0.82
In vitro activity of MSI-78 alone and in combination with antibiotics against bacteria responsible for bloodstream infections in neutropenic patients. Int J Antimicrob Agents (2005) 0.82
Characterization of the effects of opiorphin and sialorphin and their analogs substituted in position 1 with pyroglutamic acid on motility in the mouse ileum. J Pept Sci (2013) 0.82
Activity of Antimicrobial Peptides and Conventional Antibiotics against Superantigen Positive Staphylococcus aureus Isolated from the Patients with Neoplastic and Inflammatory Erythrodermia. Chemother Res Pract (2011) 0.82
In vitro activity of the synthetic lipopeptide PAL-Lys-Lys-NH(2) alone and in combination with antifungal agents against clinical isolates of Cryptococcus neoformans. Peptides (2007) 0.81
Sorption of ionic liquids onto soils: experimental and chemometric studies. Chemosphere (2012) 0.81
Homocysteine is a novel risk factor for suboptimal response of blood platelets to acetylsalicylic acid in coronary artery disease: a randomized multicenter study. Pharmacol Res (2013) 0.81
CuII binding sites located at His-96 and His-111 of the human prion protein: thermodynamic and spectroscopic studies on model peptides. Dalton Trans (2008) 0.81
Citropin 1.1-treated central venous catheters improve the efficacy of hydrophobic antibiotics in the treatment of experimental staphylococcal catheter-related infection. Peptides (2005) 0.81
Anticancer effects of CAMEL peptide. Lab Invest (2010) 0.81
Structural characterization and in vivo evaluation of β-Hairpin peptidomimetics as specific CXCR4 imaging agents. Mol Pharm (2015) 0.81
In vitro activity of amphibian peptides alone and in combination with antimicrobial agents against multidrug-resistant pathogens isolated from surgical wound infection. Peptides (2005) 0.80
In vitro activity and in vivo efficacy of the saponin diosgenyl 2-amino-2-deoxy-β-D-glucopyranoside hydrochloride (HSM1) alone and in combination with daptomycin and vancomycin against Gram-positive cocci. J Med Microbiol (2011) 0.80
In vitro activities of tachyplesin III against Pseudomonas aeruginosa. Peptides (2007) 0.80
Antitumor activity of antimicrobial peptides against U937 histiocytic cell line. Acta Biochim Pol (2011) 0.80
Therapeutic efficacy of intraperitoneal polymyxin B and polymyxin-like peptides alone or combined with levofloxacin in rat models of septic shock. J Antimicrob Chemother (2002) 0.80
In vitro activity of citropin 1.1 alone and in combination with clinically used antimicrobial agents against Rhodococcus equi. J Antimicrob Chemother (2005) 0.79
Structural elucidation of transmembrane transporter protein bilitranslocase: conformational analysis of the second transmembrane region TM2 by molecular dynamics and NMR spectroscopy. Biochim Biophys Acta (2013) 0.79
Free fatty acids in the cuticular and internal lipids of Calliphora vomitoria and their antimicrobial activity. J Insect Physiol (2013) 0.79
Raman and surface-enhanced Raman spectroscopy investigation of vasopressin analogues containing 1-aminocyclohexane-1-carboxylic acid residue. Biopolymers (2006) 0.79
Effect of cryogrinding on chemical stability of the sparingly water-soluble drug furosemide. Pharm Res (2011) 0.79
The -Cys-Cys- motif in Helicobacter pylori's Hpn and HspA proteins is an essential anchoring site for metal ions. Dalton Trans (2011) 0.79
Secreted trypanosome cyclophilin inactivates lytic insect defense peptides and induces parasite calcineurin activation and infectivity. J Biol Chem (2013) 0.79
Lipopeptide Laur-CKK-NH2 dimer preserves daptomycin susceptibility and enhances its activity against Enterococcus faecalis. J Antimicrob Chemother (2011) 0.79
In vitro activity and killing effect of uperin 3.6 against gram-positive cocci isolated from immunocompromised patients. Antimicrob Agents Chemother (2005) 0.78
Interactions of vasopressin and oxytocin receptors with vasopressin analogues substituted in position 2 with 3,3'-diphenylalanine--a molecular docking study. J Pept Sci (2013) 0.78
Human opiorphin: the lack of physiological dependence, tolerance to antinociceptive effects and abuse liability in laboratory mice. Behav Brain Res (2010) 0.78
Novel glycosylated endomorphin-2 analog produces potent centrally-mediated antinociception in mice after peripheral administration. Bioorg Med Chem Lett (2013) 0.78
Conformational studies of vasopressin and mesotocin using NMR spectroscopy and molecular modelling methods. Part II: Studies in the SDS micelle. J Pept Sci (2008) 0.78
Amphibian peptides prevent endotoxemia and bacterial translocation in bile duct-ligated rats. Crit Care Med (2006) 0.78
Synthetic amphibian peptides and short amino-acids derivatives against planktonic cells and mature biofilm of Providencia stuartii clinical strains. Pol J Microbiol (2014) 0.78
Structural analysis of a peptide fragment of transmembrane transporter protein bilitranslocase. PLoS One (2012) 0.78
Temporin A and its retro-analogues: synthesis, conformational analysis and antimicrobial activities. J Pept Sci (2006) 0.77
Antiendotoxin activity of protegrin analog IB-367 alone or in combination with piperacillin in different animal models of septic shock. Peptides (2003) 0.77
Structural characterization and antimicrobial activity of the Zn(II) complex with P113 (demegen), a derivative of histatin 5. Inorg Chem (2010) 0.77
Design of protease-resistant pexiganan enhances antileishmanial activity. Parasitol Res (2014) 0.77
Antimicrobial peptides (Temporin A and Iseganan IB-367): effect on the cysticerci of Taenia crassiceps. Mol Biochem Parasitol (2008) 0.77
In vitro activity and killing effect of temporin A on nosocomial isolates of Enterococcus faecalis and interactions with clinically used antibiotics. J Antimicrob Chemother (2005) 0.76
The His-His sequence of the antimicrobial peptide demegen P-113 makes it very attractive ligand for Cu2+. J Inorg Biochem (2008) 0.76
Activities of synthetic peptides against human pathogenic bacteria. Pol J Microbiol (2004) 0.76
Ensemble fits of restrained peptides' conformational equilibria to NMR data. Dependence on force fields: AMBER/8 ff03 versus ECEPP/3. J Mol Graph Model (2011) 0.76
Synthesis and antimicrobial activity of truncated fragments and analogs of citropin 1.1: The solution structure of the SDS micelle-bound citropin-like peptides. J Struct Biol (2009) 0.76
Release of biologically active kinin peptides, Met-Lys-bradykinin and Leu-Met-Lys-bradykinin from human kininogens by two major secreted aspartic proteases of Candida parapsilosis. Peptides (2013) 0.76
A novel mechanism of action of the fumagillin analog, TNP-470, in the B16F10 murine melanoma cell line. Anticancer Drugs (2005) 0.76
In vitro activity and killing effect of citropin 1.1 against gram-positive pathogens causing skin and soft tissue infections. Antimicrob Agents Chemother (2005) 0.76
Composition and antimicrobial activity of fatty acids detected in the hygroscopic secretion collected from the secretory setae of larvae of the biting midge Forcipomyia nigra (Diptera: Ceratopogonidae). J Insect Physiol (2012) 0.76
The antifungal activity of the cuticular and internal fatty acid methyl esters and alcohols in Calliphora vomitoria. Parasitology (2013) 0.76
Conformational studies of neurohypophyseal hormones analogues with glycoconjugates by NMR spectroscopy. J Pept Sci (2014) 0.76
Pretreatment with the protegrin IB-367 affects Gram-positive biofilm and enhances the therapeutic efficacy of linezolid in animal models of central venous catheter infection. JPEN J Parenter Enteral Nutr (2007) 0.76
Cu2+ and Ni2+ interactions with N-terminal fragments of Hpn and Hpn-like proteins from Helicobacter pylori: unusual impact of poly-Gln sequence on the complex stability. J Inorg Biochem (2010) 0.76
Effects of pexiganan alone and combined with betalactams in experimental endotoxic shock. Peptides (2005) 0.76
The C terminus of HspA--a potential target for native Ni(II) and Bi(III) anti-ulcer drugs. Dalton Trans (2010) 0.76
Highly potent antidiuretic antagonists: conformational studies of vasopressin analogues modified with 1-naphthylalanine enantiomers at position 2. Chem Biol Drug Des (2012) 0.76
Determination of counter-ions in synthetic peptides by ion chromatography, capillary isotachophoresis and capillary electrophoresis. J Pept Sci (2012) 0.76
Conformational solution studies of the anti-microbial temporin A retro-analogues by using NMR spectroscopy. J Pept Sci (2007) 0.76
Competition between histamine-like and poly-imidazole coordination sites for Cu(2+) and Zn(2+) ions in zebra-fish peptide of prion-like protein. Dalton Trans (2010) 0.75
Serum Metabolite Profiles Are Altered by Erlotinib Treatment and the Integrin α1-Null Genotype but Not by Post-Traumatic Osteoarthritis. J Proteome Res (2016) 0.75
Temporin A soaking in combination with intraperitoneal linezolid prevents vascular graft infection in a subcutaneous rat pouch model of infection with Staphylococcus epidermidis with intermediate resistance to glycopeptides. Antimicrob Agents Chemother (2004) 0.75
Efficacy of the combination of tachyplesin III and clarithromycin in rat models of Escherichia coli sepsis. Antimicrob Agents Chemother (2008) 0.75